Introduction
Traditionally, safety engineering focused on random hardware failures or software bugs. Today, we must account for intentional, malicious acts. Cybersecurity Risk Management is the process of protecting medical systems from unauthorized access or modification.
The challenge is that security is dynamic. Unlike a mechanical part with a known wear-and-rate, a software vulnerability can be discovered today in a library that was considered safe yesterday. This requires a transition from a “point-in-time” assessment to continuous Vulnerability Management.
The Regulatory Framework: AAMI TIR57 & FDA Guidance
The cornerstone of modern compliance is AAMI TIR57, which provides a framework for integrating cybersecurity into the existing ISO 14971 risk management process.
- ISO 14971 focuses on Safety Risks (Source -> Hazard -> Harm).
- AAMI TIR57 focuses on Security Risks (Threat -> Vulnerability -> Impact).
By integrating AAMI TIR57 with ISO 14971, manufacturers can see how a security breach (e.g., a malware infection) directly creates a safety hazard (e.g., the device stops delivering therapy).
Threat Modeling: The Attacker’s Perspective
A robust Cybersecurity Risk Assessment begins with Threat Modeling. This is a systematic exercise to identify potential attack vectors:
- Physical: Unauthorized USB access.
- Network: Intercepting Wi-Fi or Bluetooth transmissions.
- Supply Chain: Compromised third-party software libraries.
By identifying these threats early, engineers can implement security requirements—such as encryption, secure boot, and multi-factor authentication—as core design inputs.
The Software Bill of Materials (SBOM)
One of the most significant FDA Cybersecurity Guidance requirements is the Software Bill of Materials (SBOM). An SBOM is a nested inventory, a list of ingredients for your software. It must include:
- Open-source libraries.
- Commercial “off-the-shelf” software.
- Version numbers and patch levels.
SBOM requirements for FDA submission are now mandatory because they allow hospitals and manufacturers to quickly identify if they are at risk when a new CVE (Common Vulnerabilities and Exposures) is announced.
Vulnerability Management and CVSS Scoring
Identifying a vulnerability is only half the battle; you must know how to prioritize it. The industry uses the CVSS (Common Vulnerability Scoring System) to provide a numerical score reflecting the severity of a vulnerability.
- Low CVSS: Requires local access and high complexity to exploit.
- Critical CVSS: Can be exploited remotely with low complexity and high impact.
Effective Vulnerability Management involves scanning your SBOM against databases like the CWE (Common Weakness Enumeration) to proactively patch weaknesses before they are exploited.
Legacy Devices and Patch Management
Perhaps the greatest challenge in MedTech is managing legacy medical device cybersecurity. Many devices in hospitals today were designed before cybersecurity was a priority. Manufacturers must now develop a Post-Market Cybersecurity Plan that includes:
- Regular security patches.
- Obsolescence management for third-party software.
- Clear communication to users about “End of Life” security support.
Visure’s Role: Securing the Digital Thread
Cybersecurity is too complex for manual tracking. Visure Requirements ALM acts as the central nervous system for your security strategy:
- Integrated Threat Matrices: Map threats directly to safety hazards and mitigation requirements within a single platform.
- SBOM Traceability: Link items in your Software Bill of Materials to the specific system requirements they support.
- Vulnerability Alerts: By integrating with vulnerability databases, Visure can flag a requirement as “at-risk” if a new CVE is discovered for a linked software component.
- Automated Compliance Documentation: Generate the cybersecurity reports required for FDA RTA (Refuse to Accept) reviews, including your threat models and mitigation verification results.
- Vivia AI Support: Use Vivia to conduct “Security Requirement Reviews,” identifying weak spots in your encryption or authentication logic before they reach the coding stage.
Conclusion
Cybersecurity Risk Management for Medical Devices is no longer optional; it is a prerequisite for market entry and a moral imperative for patient protection. By moving from a reactive “patch-and-pray” mindset to a proactive AAMI TIR57 framework, manufacturers can build devices that are not only clinically effective but also resilient against the evolving threats of the digital age.
When security is “baked into” the requirements and traced through the entire lifecycle, compliance becomes a natural byproduct of good engineering.
Check out the free trial at Visure and experience how AI-driven change control can help you manage changes faster, safer, and with full audit readiness.
